Are GLP-1 Drugs Here to Stay?
We recently spoke with Nicole Bulochnik, senior vice president of drug strategy for Abarca, about what payers need to consider as demand for this group of weight-loss drugs remains high.
presented by
presented by
How AI and Machine Learning Can Transform Pharmacy Benefits Management
Abarca executives see plenty of potential for new technologies but note the need to strike the right balance between tech and human intervention.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
presented by
Unlocking Transparency in PBM Pricing
Dan Reedy, senior director of pricing and underwriting for Abarca, spoke recently with MedCity News about what payers should consider as they explore new models and press for greater transparency.
Health Exec: Food-as-Medicine Will Change How Healthcare Is Delivered With or Without GLP-1s
During a panel discussion on GLP-1s at the Abarca Forward conference, one health executive stressed the importance of a food-as-medicine approach.
What Are the Challenges Facing the Pharmacy Industry Right Now?
The regulatory environment and workforce shortages are plaguing the pharmacy industry, one Walgreens exec shared at the Abarca Forward conference on Tuesday.